Clinical Trials Logo

Filter by:
NCT ID: NCT01491737 Completed - Breast Cancer Clinical Trials

A Study of Pertuzumab in Combination With Trastuzumab Plus an Aromatase Inhibitor in Participants With Metastatic Human Epidermal Growth Factor Receptor 2 (HER2)-Positive and Hormone Receptor-Positive Advanced Breast Cancer

PERTAIN
Start date: February 17, 2012
Phase: Phase 2
Study type: Interventional

This randomized, open-label, two-arm, multi-center, Phase II study will evaluate the efficacy and safety of pertuzumab in combination with trastuzumab plus an aromatase inhibitor (AI) in first-line participants with HER2-positive and hormone receptor-positive advanced breast cancer. Participants will be randomized to one of two treatment arms; Arm A (pertuzumab in combination with trastuzumab plus an AI) or Arm B (trastuzumab plus an AI). Participants may also receive induction chemotherapy (a taxane, either docetaxel or paclitaxel) at the investigator's discretion in combination with the assigned treatment arm. The anticipated time on study treatment is until disease progression, unacceptable toxicity, withdrawal of consent, or death whichever occurs first.

NCT ID: NCT01491672 Completed - Clinical trials for Metastatic Renal Cell Carcinoma

Everolimus as Second-line Therapy in Metastatic Renal Cell Carcinoma

RECORD-4
Start date: November 2011
Phase: Phase 2
Study type: Interventional

This study will evaluate everolimus as second-line therapy in patients with metastatic renal cell carcinoma. Each patient will be enrolled and stratified in one of three cohorts based upon their first-line therapy: 1) prior cytokines, 2) prior sunitinib, or 3) prior anti-VEGF therapy other than sunitinib.

NCT ID: NCT01491048 Completed - Osteoarthritis, Hip Clinical Trials

Evaluation of Functional Rehabilitation in Patients Undergoing Physiotherapy After Total Hip Arthroplasty

Artrhosis
Start date: July 2009
Phase: N/A
Study type: Interventional

This study aims to objectively evaluate the implications of physiotherapeutic rehabilitation in the Assistance Protocol of Total Hip Arthroplasty (THA), by assessing the motor performance and testing the quality of life of patients undergoing THA surgery, to improve rehabilitation strategies for this population.

NCT ID: NCT01489111 Completed - Clinical trials for Congenital Bleeding Disorder

Evaluating the Haemostatic Effect of NNC 0129-0000-1003 During Surgical Procedures in Subjects With Haemophilia A.

pathfinder™3
Start date: August 3, 2012
Phase: Phase 3
Study type: Interventional

This trial is conducted globally. The aim of this trial is to evaluate the haemostatic effect of NNC 0129-0000-1003 during surgical procedures in subjects with haemophilia A.

NCT ID: NCT01488760 Completed - Clinical trials for Abnormally Decreased Muscle Contraction

Abdominal Wall Evaluation in Low Back Pain

Start date: December 2009
Phase: N/A
Study type: Observational

The purpose of this study was to evaluate feed-forward contraction of the transversus abdominis and thickness of the transversus abdominis, obliquus internus, and obliquus externus during calm and standardized respiration in low back pain patients and pain-free subjects.

NCT ID: NCT01487629 Active, not recruiting - Clinical trials for Diabetic Retinopathy

Bevacizumab Versus Ranibizumab for the Treatment of Diabetic Macular Edema

IBERA-DME
Start date: April 2010
Phase: Phase 2
Study type: Interventional

The purpose of this study is to compare the morphological and visual acuity outcomes associated with 1.5 mg bevacizumab versus 0.5 ranibizumab intravitreal injections for treatment of diabetic macular edema.

NCT ID: NCT01487291 Completed - Insulin Resistance Clinical Trials

Prevalence of Clinical and Laboratory Markers of Hypofibrinolysis in Psychotic Patients

Start date: January 2013
Phase: N/A
Study type: Observational

At the Thrombophilia Clinic of the Hospital Federal dos Servidores do Estado do Rio de Janeiro there is a high prevalence of acute psychotic episodes, which allows the investigators to raise the suspicion that the thrombotic tendency or hypofibrinolysis play a role in the onset of the disease. It is striking that most of these patients, after some time on anticoagulants, no longer need to take psychiatric medication.

NCT ID: NCT01487083 Terminated - Schizophrenia Clinical Trials

A Long-Term Study in Schizophrenia

Start date: December 2011
Phase: Phase 3
Study type: Interventional

The purpose of this study is to evaluate the long-term safety of pomaglumetad methionil in participants with schizophrenia.

NCT ID: NCT01486069 Completed - Clinical trials for Maxillofacial Abnormalities

Mandibular Stability and Dentofacial Deformity

Start date: July 2012
Phase: N/A
Study type: Observational

The present study intends to clarify whether there is positional mandibular stability in patients to be submitted to orthognathic surgery. In case of any instability exists, it is needed to understand if this could be related to a particular type of dentofacial deformity or could have any short-term or long-term influence on outcomes of the orthognathic surgery.

NCT ID: NCT01485991 Completed - Hepatitis C Clinical Trials

TMC435HPC3001 - An Efficacy, Safety and Tolerability Study for TMC435 vs Telaprevir in Combination With PegINFα-2a and Ribavirin in Chronic Hepatitis C Patients Who Were Null or Partial Responders to Prior PegINFα-2a and Ribavirin Therapy

ATTAIN
Start date: February 2012
Phase: Phase 3
Study type: Interventional

The purpose of this study is to demonstrate the efficacy of TMC435 in combination with peginterferon (PegIFN) + ribavirin (RBV) by means of establishing its non- inferiority compared to an approved regimen of telaprevir + PegIFN + RBV in patients who have previously failed PegIFN.